Amgen details direct move

AMGEN says changes to the distribution model for its osteoporosis medication Prolia (PD yesterday) will include a range of commercial deals for all community pharmacies.

The controversial change will see distribution of Prolia managed by DHL effective from 01 Dec, rather than through the major wholesalers, with the company saying the new model “provides greater visibility of stock transport, allowing us to trace every batch to the individual pharmacy.

“DHL are offering the latest technology in cold chain delivery, and pharmacies will receive Prolia in a DHL cold chain box,” the company said.

Amgen said it would provide guidance and support to community pharmacies over the coming weeks to ensure a smooth transition to the new Prolia distribution model.

“The efficiencies provided by this new model will enable Amgen to support community pharmacy through the provision of in-pharmacy customer programs, the first of which will be launching soon,” a spokesperson told Pharmacy Daily.

Pharmacists play a key role in the management of patients with osteoporosis, Amgen said, with the company recognising community pharmacy as a key partner to improve patient engagement and compliance.

“We are committed to working with community pharmacy to increase the diagnosis and treatment of osteoporosis - a chronic condition that currently is largely undiagnosed,” the spokesperson added.

Amgen’s move to bypass wholesalers for Prolia distribution follows the recent switch by AstraZeneca, which this month started delivering nine high-cost medications to pharmacy, also in partnership with DHL.